Southern Acids (M) Berhad Dirección

Dirección controles de criterios 3/4

El CEO de Southern Acids (M) Berhad's es Nick Low , nombrado en Jul 2015, tiene una permanencia de 8.75 años. compensación anual total es MYR926.72K, compuesta por 54.5% salario y 45.5% primas, incluidas acciones y opciones de la empresa. posee directamente un 0.071% de las acciones de la empresa, por valor de MYR314.37K. La antigüedad media del equipo directivo y de la junta directiva es de 10.5 años y 9.2 años, respectivamente.

Información clave

Nick Low

Chief Executive Officer (CEO)

RM 926.7k

Compensación total

Porcentaje del salario del CEO	54.5%
Permanencia del CEO	8.9yrs
Participación del CEO	0.07%
Permanencia media de la dirección	10.7yrs
Promedio de permanencia en la Junta Directiva	9.4yrs

Actualizaciones recientes de la dirección

Recent updates

Southern Acids (M) Berhad's (KLSE:SAB) Soft Earnings Are Actually Better Than They Appear

Mar 03

If You Like EPS Growth Then Check Out Southern Acids (M) Berhad (KLSE:SAB) Before It's Too Late

May 27

The Returns At Southern Acids (M) Berhad (KLSE:SAB) Aren't Growing

Apr 19

Are Strong Financial Prospects The Force That Is Driving The Momentum In Southern Acids (M) Berhad's KLSE:SAB) Stock?

Feb 24

Returns On Capital At Southern Acids (M) Berhad (KLSE:SAB) Paint An Interesting Picture

Jan 13

What Can We Learn About Southern Acids (M) Berhad's (KLSE:SAB) CEO Compensation?

Dec 15

Southern Acids (M) Berhad (KLSE:SAB) Share Prices Have Dropped 14% In The Last Three Years

Nov 24

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Nick Low en comparación con los beneficios de Southern Acids (M) Berhad?
Fecha	Compensación total	Salario	Ingresos de la empresa
Mar 31 2024	n/a	n/a	RM 14m
Dec 31 2023	n/a	n/a	-RM 1m
Sep 30 2023	n/a	n/a	RM 11m
Jun 30 2023	n/a	n/a	RM 28m
Mar 31 2023	RM 927k	RM 505k	RM 33m
Dec 31 2022	n/a	n/a	RM 69m
Sep 30 2022	n/a	n/a	RM 80m
Jun 30 2022	n/a	n/a	RM 86m
Mar 31 2022	RM 874k	RM 463k	RM 94m
Dec 31 2021	n/a	n/a	RM 74m
Sep 30 2021	n/a	n/a	RM 53m
Jun 30 2021	n/a	n/a	RM 44m
Mar 31 2021	RM 727k	RM 421k	RM 37m
Dec 31 2020	n/a	n/a	RM 40m
Sep 30 2020	n/a	n/a	RM 44m
Jun 30 2020	n/a	n/a	RM 44m
Mar 31 2020	RM 712k	RM 414k	RM 32m
Dec 31 2019	n/a	n/a	RM 24m
Sep 30 2019	n/a	n/a	RM 19m
Jun 30 2019	n/a	n/a	RM 19m
Mar 31 2019	RM 699k	RM 390k	RM 21m
Dec 31 2018	n/a	n/a	RM 29m
Sep 30 2018	n/a	n/a	RM 35m
Jun 30 2018	n/a	n/a	RM 32m
Mar 31 2018	RM 649k	RM 366k	RM 33m

Compensación vs. Mercado: La compensación total de Nick($USD193.98K) está por encima de la media de empresas de tamaño similar en el mercado MY ($USD104.01K).

Compensación vs. Ingresos: La compensación de Nick ha sido consistente con los resultados de la empresa en el último año.

CEO

Nick Low (45 yo)

8.9yrs

Permanencia

RM 926,715

Compensación

Dr. Kok Thye Low , also known as Nick, has been Managing Director and Director of Southern Acids M Bhd since July 2015. Dr. Low served as a Director In-Lead of Oleochemical and Health Care Divisions at Sou...

Equipo directivo

Nombre	Posición	Permanencia	Compensación	Propiedad
Kok Low	MD & Non-Independent Executive Director	8.9yrs	RM 926.72k	0.071% MYR 328.9k
Kim Lim	Non-Independent Executive Director	15.8yrs	RM 747.52k	2.32% MYR 10.8m
Kee Cheong	Chief Financial Officer	10.7yrs	sin datos	sin datos
Thevakumar Kaliaperumal	General Manager of Operations	1.4yrs	sin datos	sin datos
Chuu Tiong	Chief Operating Officer of Oleochemical Manufacturing Segment	13.4yrs	sin datos	sin datos
Choon Chan	Chief Strategic Development Officer	no data	sin datos	sin datos
Kui Lim	Company Secretary	15.8yrs	sin datos	sin datos
Shu Ng	Company Secretary	1.3yrs	sin datos	sin datos

10.7yrs

Permanencia media

55yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de SAB es experimentado (10.5 años antigüedad media).

Miembros de la Junta

Nombre	Posición	Permanencia	Compensación	Propiedad
Kok Low	MD & Non-Independent Executive Director	8.9yrs	RM 926.72k	0.071% MYR 328.9k
Kim Lim	Non-Independent Executive Director	18.8yrs	RM 747.52k	2.32% MYR 10.8m
Kin Chung	Non Independent Non Executive Director	12.3yrs	RM 154.20k	sin datos
Sulong bin Matjeraie	Independent Non-Executive Chairman	9.8yrs	RM 151.80k	sin datos
Yeng Wan	Independent & Non Executive Director	1.3yrs	RM 986.00	sin datos
Deborah Choa	Independent Non-Executive Director	less than a year	sin datos	sin datos

9.4yrs

Permanencia media

57yo

Promedio de edad

Junta con experiencia: La junta directiva de SAB se considera experimentada (9.2 años de antigüedad promedio).

Southern Acids (M) Berhad Dirección

Dirección controles de criterios 3/4

Información clave

Actualizaciones recientes de la dirección

Southern Acids (M) Berhad Announces Redesignation of Chung Kin Mun from Independent Director to Non Independent and Non Executive Director

Southern Acids (M) Berhad Announces Redesignation of Stephen Wan Yeng Leong from Member of Audit Committee to Independent and Non Executive Chairman of Audit Committee

Southern Acids (M) Berhad Announces Appointment of Deborah Deb-Bie Choa as Independent and Non Executive Director

Southern Acids (M) Berhad, Annual General Meeting, Aug 30, 2023

Southern Acids (M) Berhad Announces Cessation of Office of Madam Leong So Seh as Member of Nomination and Remuneration Committee

Insufficient new directors

Recent updates

New minor risk - Market cap size

Full year 2024 earnings released: EPS: RM0.10 (vs RM0.24 in FY 2023)

Southern Acids (M) Berhad Announces Redesignation of Chung Kin Mun from Independent Director to Non Independent and Non Executive Director

Third quarter 2024 earnings released: EPS: RM0.033 (vs RM0.12 in 3Q 2023)

Southern Acids (M) Berhad Announces Redesignation of Stephen Wan Yeng Leong from Member of Audit Committee to Independent and Non Executive Chairman of Audit Committee

Southern Acids (M) Berhad (KLSE:SAB) entered into agreement to acquire remaining 10% stake in Firstview Development Sdn Bhd from Low Mong Hua Sdn Berhad for RM 23.5 million.

Second quarter 2024 earnings released: RM0.039 loss per share (vs RM0.081 profit in 2Q 2023)

Upcoming dividend of RM0.05 per share at 1.5% yield

Southern Acids (M) Berhad Announces Appointment of Deborah Deb-Bie Choa as Independent and Non Executive Director

First quarter 2024 earnings released: EPS: RM0.067 (vs RM0.11 in 1Q 2023)

New minor risk - Market cap size

Full year 2023 earnings released: EPS: RM0.24 (vs RM0.69 in FY 2022)

Southern Acids (M) Berhad, Annual General Meeting, Aug 30, 2023

Southern Acids (M) Berhad Announces Cessation of Office of Madam Leong So Seh as Member of Nomination and Remuneration Committee

Full year 2023 earnings released: EPS: RM0.24 (vs RM0.69 in FY 2022)

Outhern Acids (M) Berhad Recommends Single Tier Final Dividend in Respect of the Financial Year Ended 31 March 2023

Southern Acids (M) Berhad's (KLSE:SAB) Soft Earnings Are Actually Better Than They Appear

Third quarter 2023 earnings released: EPS: RM0.12 (vs RM0.20 in 3Q 2022)

Second quarter 2023 earnings released: EPS: RM0.082 (vs RM0.13 in 2Q 2022)

Price target decreased to RM3.40

Insufficient new directors

Upcoming dividend of RM0.05 per share

Full year 2022 earnings released: EPS: RM0.69 (vs RM0.27 in FY 2021)

Southern Acids (M) Berhad Announces Final Dividend, Payable on 28 Nov. 2022

Southern Acids (M) Berhad Recommends Single Tier Final Dividend for the Financial Year Ended March 31, 2022

Full year 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Price target decreased to RM3.40

Insufficient new directors

Third quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Second quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

First quarter 2022 earnings released: EPS RM0.17 (vs RM0.13 in 1Q 2021)

Upcoming dividend of RM0.05 per share

Full year 2021 earnings released: EPS RM0.27 (vs RM0.23 in FY 2020)

Price target decreased to RM3.40

Full year 2021 earnings released: EPS RM0.27 (vs RM0.23 in FY 2020)

If You Like EPS Growth Then Check Out Southern Acids (M) Berhad (KLSE:SAB) Before It's Too Late

Southern Acids (M) Berhad Recommends Final Dividend for the Year Ended March 31, 2021

The Returns At Southern Acids (M) Berhad (KLSE:SAB) Aren't Growing

Third quarter 2021 earnings released: EPS RM0.041 (vs RM0.076 in 3Q 2020)

Are Strong Financial Prospects The Force That Is Driving The Momentum In Southern Acids (M) Berhad's KLSE:SAB) Stock?

Returns On Capital At Southern Acids (M) Berhad (KLSE:SAB) Paint An Interesting Picture

What Can We Learn About Southern Acids (M) Berhad's (KLSE:SAB) CEO Compensation?

New 90-day high: RM3.88

Southern Acids (M) Berhad Announces Appointment of Tan Sri Datuk Seri Panglima Sulong Bin Matjeraie as Independent and Non Executive Ember of Audit Committee

Second quarter 2021 earnings released: EPS RM0.06

Southern Acids (M) Berhad (KLSE:SAB) Share Prices Have Dropped 14% In The Last Three Years

New 90-day high: RM3.80

Southern Acids (M) Berhad Announces the Resignation of Encik Teo Leng as Independent and Non Executive Member of Audit Committee

New 90-day high: RM3.72

Upcoming Dividend of RM0.05 Per Share

First quarter earnings released

New 90-day high - RM3.68

Análisis de compensación del CEO

CEO

Permanencia

Compensación

Equipo directivo

Permanencia media

Promedio de edad

Miembros de la Junta

Permanencia media

Promedio de edad